Results 61 to 70 of about 4,399,583 (292)

In Vitro Hemocompatibility Evaluation of Modified Rotary Left to Right Ventricular Assist Devices in Pulmonary Flow Conditions

, 2020
Right ventricular failure is a common postoperative com-plication following left ventricular assist device (LVAD) im-plantation. Left ventricular assist devices are adapted for right ventricular assist device (RVAD) support by reducing the right pump ...
Andrew Stephens, Michael J. Simmonds, Tansley, Geoff, Nicoletta Balletti, Gregory, Shaun D, Geoff Tansley, Wu, Eric Lee-Jan, Jo P. Pauls, Chan, Chris Hoi Houng, Horobin, Jarod, John F. Fraser, Bouquet, Mahe, Chris Hoi Houng Chan, Nandakumar, Deepika, Pauls, Jo P, Stephens, Andrew, Mahe Bouquet, Balletti, Nicoletta, Shaun D. Gregory, Jarod Horobin, Deepika Nandakumar, Eric Lee-Jan Wu, Fraser, John F, Simmonds, Michael J   +23 more
core   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

Advanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng, Yuxue Cao, Maria Kavallaris, Taskeen Janjua, Amirali Popat   +4 more
wiley   +1 more source

Reduced Graphene Oxide Enhances the Vascular Organization and Contractile Performance of Fibrin‐Gelatin‐Based Engineered Cardiac Tissue

Advanced Materials Interfaces, EarlyView.
Fibrin–gelatin hydrogels functionalized with reduced graphene oxide create a mechanically stable and bioactive 3D environment for engineered cardiac tissue. The composite matrix promotes endothelial lumen formation, enhances sarcomeric protein expression, and increases contractile performance of embedded cardiomyocytes.
Christoph Kuckelkorn, Marie Baiker, Yajuan Jiang, Ebru Aksoy, Kurt Pfannkuche, Horst Fischer   +5 more
wiley   +1 more source

Left ventricular assist device.

New England Journal of Medicine, 2002
To the Editor: The value of angiotensin-converting– enzyme (ACE) inhibitors, beta-blockers, and spironolactone has been well established by the results of numerous clinical trials. About 70 percent of the patients described by Rose et al. were treated with ACE inhibitors or angiotensin II–receptor antagonists; 35 to 40 percent received spironolactone ...
Jiménez-Navarro, Manuel, Molero, Encarnación, Teresa, Eduardo de   +2 more
openaire   +3 more sources

Non-invasive assessment of arterial pulsatility in patients with continuous-flow left ventricular assist devices

, 2019
Introduction: Long-term use of continuous-flow left ventricular assist devices may have negative consequences for autonomic, cardiovascular and gastrointestinal function.
Fabian, Vratislav, Johnson, Bruce D, Maltais, Simon, Sajgalik, Pavol, Kushwaha, Sudhir S, Matera, Lukas, Schirger, John A, Cross, Troy J, Stulak, John M   +8 more
core   +1 more source

A Constraint‐Based Analytical Framework for Design‐Space Analysis and Material Screening of Tubular Multilayer Dielectric Elastomer Pumps for Extracorporeal Circulatory Applications

Advanced Materials Technologies, EarlyView.
A constraint‐based analytical framework maps the coupled effects of material properties, structural parameters, and operating conditions in tubular dielectric elastomer pumps for extracorporeal circulatory applications. The approach defines performance boundaries through mechanical, electrical, and hydraulic constraints and identifies feasible design ...
Yan Zhang, Amine Benouhiba, Yoan Civet, Yves Perriard   +3 more
wiley   +1 more source

Bowel obstruction due to retained intraperitoneal left ventricular assist device (LVAD) driveline

Journal of Cardiothoracic Surgery, 2018
Background Left ventricular assist devices (LVAD) provide a lifesaving bridge to cardiac transplant. Utilization of these devices is increasing in the United States.
Daniel Miklin, Ivy Lewis, Howard Lieberman   +2 more
doaj   +1 more source

The Lebanese left ventricular assist device experience, a success story despite the odds

Journal of Cardiothoracic Surgery, 2020
Background and aim Heart failure is still a leading cause of mortality and morbidity. Assist devices are reserved for advanced heart failure patients with no other therapeutic options.
R. Hamdan, S. Fakih, M. Mohammad, F. Charif, H. Abdallah, S. Safa, F. Al Ali, M. Issa, B. Damen, A. el Zein, M. Younes, A. Rabah, M. Saab   +12 more
doaj   +1 more source

Extrusion‐Based Bioprinting of Living Bioinks for Tissue and Organ Engineering

Advanced Materials Technologies, EarlyView.
Extrusion‐based bioprinting is presented as the most versatile route for fabricating living, heterogeneous tissues. Its ability to combine diverse bioinks, support matrices, and advanced printhead geometries transforms familiar constraints into powerful biofabrication opportunities.
Eric Silberman, Ester Sapir Baruch, Roni Cohen, Assaf Shapira, Tal Dvir   +4 more
wiley   +1 more source

Iron Deficiency in Patients with Left Ventricular Assist Devices

Cardiac Failure Review
Iron deficiency is a common and independent predictor of adverse outcomes in patients with heart failure. The implications of iron deficiency in patients implanted with a left ventricular assist device (LVAD) are less established. This review recaps data
William Herrik Nielsen, Finn Gustafsson
doaj   +1 more source